( December 30, 2024, 10:14 AM EST) -- WASHINGTON, D.C. — The manufacturer of Depo-Provera
XE "Depo-Provera" , a long-lasting injectable contraceptive, agreed that cases alleging that the product caused women to develop intracranial meningiomas, a type of brain tumor, should be centralized by the U.S. Judicial Panel on Multidistrict Litigation but argued that the Southern District of New York is the most appropriate forum....